Subscribe To Our Free Newsletter |
Why did investors dump Marksans Pharma shares post Q4 results? Know here
Marksans Pharma's net profit fell 4.5 per cent on a year-on-year (Y-o-Y) basis to Rs 78.3 crore in the March quarter of FY24, from Rs 82 crore in the March quarter of FY23